Overview
Malignant neoplasms of the face represent a complex and challenging subset of head and neck cancers, often requiring multidisciplinary management due to their impact on both function and aesthetics. These tumors can arise from various primary sites, including the oral cavity, larynx, parotid gland, and less commonly, deeper structures like the paranasal sinuses. Given the intricate anatomy of the face, treatment strategies must meticulously balance oncologic principles with reconstructive goals to preserve function and quality of life. This guideline synthesizes evidence from key studies to provide clinicians with a comprehensive approach to the clinical presentation, diagnosis, management, complications, prognosis, and follow-up care for patients with malignant neoplasms of the face.
Clinical Presentation
Patients presenting with malignant neoplasms of the face often exhibit a range of symptoms that reflect the tumor's location and extent. Common clinical manifestations include facial asymmetry, ulceration, mass formation, and changes in speech and swallowing patterns. A critical aspect of initial assessment involves ensuring that reconstructive planning addresses functional impairments. For instance, studies highlight the necessity of reconstructing defects in a manner that maintains separation between the nasal passages, orbit, and oral cavity to prevent complications such as dysphagia and articulation disorders [PMID:24771201]. This separation is crucial for preserving nasal breathing, which significantly impacts patient comfort and quality of life post-treatment. Additionally, the involvement of the submandibular gland can lead to ptosis, a phenomenon characterized by the descent of the gland. A novel grading system categorizes submandibular gland ptosis into grades I-IV based on the distance from the mandible, with an average descent rate of 0.17 mm per year [PMID:23884853]. This grading system not only aids in the clinical assessment but also guides plastic surgeons in planning reconstructive interventions tailored to the extent of gland descent.
Diagnosis
Diagnosing malignant neoplasms of the face typically involves a combination of clinical examination and advanced imaging techniques. Clinical examination provides initial clues regarding the tumor's size, location, and potential involvement of adjacent structures. However, definitive diagnosis and staging rely heavily on imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). CT imaging studies have shown a significant correlation between age and submandibular gland ptosis, offering a quantifiable metric that can assist in both diagnosis and monitoring disease progression [PMID:23884853]. This correlation underscores the importance of longitudinal imaging in assessing the natural history of these tumors and their impact on surrounding structures. Furthermore, imaging can help delineate the extent of tumor invasion, guiding decisions on surgical resection margins and the need for adjuvant therapies.
Management
The management of malignant neoplasms of the face is multifaceted, encompassing surgical resection, reconstructive surgery, and often adjuvant therapies such as radiation and chemotherapy. Surgical approaches vary based on tumor characteristics and location but frequently involve complex reconstructive techniques to restore both form and function. A series of ten patients with midfacial tumor defects demonstrated that the use of various free flaps (including anterolateral thigh, radial forearm, and fibular flaps) alongside extraoral implants and prosthetic work achieved reasonable functional and aesthetic outcomes [PMID:24771201]. These reconstructive strategies are essential for addressing the intricate anatomy of the face, ensuring that critical functions such as breathing, swallowing, and speech are preserved. Additionally, the proposed grading system for submandibular gland ptosis can guide plastic surgeons in planning facial rejuvenation surgeries, optimizing outcomes by accounting for the extent of gland descent [PMID:23884853]. In more cosmetic contexts, a prospective study of 100 deep plane face-lifts showed no persistent problems, facial irregularities, paralysis, or paresis, with a low rate of hematomas and 97% patient satisfaction [PMID:8554742]. This evidence supports the safety and efficacy of facial rejuvenation techniques when performed by experienced surgeons, highlighting the importance of meticulous surgical technique in minimizing complications.
Complications
Despite advancements in surgical techniques and reconstructive strategies, complications remain a significant concern in the management of malignant neoplasms of the face. One common issue involves the integration of extraoral implants used in reconstructive procedures. On average, four extraoral implants were inserted per patient, but complications such as non-osseointegration occurred in seven implants across four patients, necessitating their removal [PMID:24771201]. This highlights the variability in implant success rates and the need for careful patient selection and meticulous surgical placement. Additionally, while deep plane face-lifts showed minimal complications, it is crucial to monitor for potential hematomas, especially given the thick tissue flaps involved. Fortunately, none of the 100 patients in the study experienced hematomas beneath the cheek flaps, and there were no reports of facial nerve paralysis or paresis [PMID:8554742]. Nonetheless, vigilance remains essential to promptly address any signs of nerve injury or vascular compromise, which can significantly impact patient recovery and outcomes.
Prognosis & Follow-up
The prognosis for patients with malignant neoplasms of the face varies widely depending on factors such as tumor stage, histological type, and the effectiveness of treatment modalities employed. Follow-up care is critical for monitoring both functional outcomes and survival. In a series of patients, eight were reported to be free of recurrence, underscoring the importance of thorough initial treatment and close surveillance [PMID:24771201]. However, the tragic case of one patient who died during follow-up emphasizes the ongoing risk of recurrence and the necessity for rigorous long-term monitoring. Postoperative assessments should include regular imaging studies, clinical examinations, and patient-reported outcomes to evaluate both oncologic control and quality of life improvements. Photographic analysis and patient questionnaires conducted six months post-surgery indicated significant and sustained aesthetic improvements, with high patient satisfaction scores [PMID:8554742]. These qualitative measures are invaluable in assessing the holistic impact of treatment on patients' well-being and self-image.
Key Recommendations
These recommendations are informed by expert clinical experience and supported by evidence from key studies, aiming to optimize outcomes for patients facing the multifaceted challenges posed by malignant neoplasms of the face.
References
1 Mueller S, Hohlweg-Majert B, Buergers R, Steiner T, Reichert TE, Wolff KD et al.. The functional and aesthetic reconstruction of midfacial and orbital defects by combining free flap transfer and craniofacial prosthesis. Clinical oral investigations 2015. link 2 Lee MK, Sepahdari A, Cohen M. Radiologic measurement of submandibular gland ptosis. Facial plastic surgery : FPS 2013. link 3 Kamer FM. One hundred consecutive deep plane face-lifts. Archives of otolaryngology--head & neck surgery 1996. link